State Street SPDR S&P Emerging Markets ex-China ETF (XCNY) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
Beta 0.31: the stock has moved about 69% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerState Street SPDR S&P Emerging Markets ex-China ETF (XCNY) trades at $33.96. Sector: Financials.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for XCNY: XCNY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
State Street SPDR S&P Emerging Markets ex-China ETF (XCNY) Financial Services Profile
State Street SPDR S&P Emerging Markets ex-China ETF (XCNY) provides targeted exposure to emerging markets, excluding China, by tracking the S&P Emerging ex-China BMI. It offers investors a tool to manage China-specific risk while participating in the growth potential of other developing economies through a market capitalization-weighted approach.
What Is the Investment Thesis for XCNY?
XCNY presents a targeted investment vehicle for investors seeking exposure to emerging markets while mitigating China-specific risks. With a beta of 0.31, the ETF demonstrates lower volatility compared to the broader market, potentially offering a more stable investment in turbulent times. The primary value driver is the growth potential of emerging economies outside of China, driven by factors such as increasing urbanization, rising middle classes, and technological advancements. Upcoming catalysts include favorable trade agreements and infrastructure development projects in key emerging markets. However, investors may want to evaluate potential risks such as currency fluctuations and political instability in these regions.
Based on FMP financials and quantitative analysis
XCNY Key Highlights
XCNY's investment objective is to replicate the performance of the S&P Emerging ex-China BMI, offering targeted exposure to emerging markets excluding China.
- The ETF's beta of 0.31 indicates lower volatility compared to the broader market, potentially providing a more stable investment.
- XCNY allows investors to manage their China risk exposure separately, which can be beneficial for those with existing China exposure.
- The fund focuses on high growth and capital appreciation potential from emerging market economies outside of China.
- XCNY's market capitalization-weighted approach ensures that the ETF accurately reflects the performance of the underlying index.
Who Are XCNY's Competitors?
XCNY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| EMOP Alliance Bernstein - AB Emerging Markets Opportunities ETF | $51.29 | +0.43% | $2.11B | — |
| EPEM Harbor Emerging Markets Equity ETF (EPEM) | $30.19 | 0.00% | $8.25M | — |
| EPIN Harbor International Equity ETF (EPIN) | $28.02 | 0.00% | $7.70M | — |
| FTAG First Trust Indxx Global Agriculture ETF | $28.78 | +0.84% | $6.27M | — |
| BLK BlackRock, Inc. | $1059.63 | -0.44% | $164B | 51 5-pillar |
| BX Blackstone Inc. | $111.74 | -0.45% | $135B | 68 5-pillar |
| APOS Apollo Global Management, Inc. | $25.59 | -0.23% | $74.8B | 56 5-pillar |
| BAM Brookfield Asset Management | $44.85 | +0.65% | $71.6B | 57 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are XCNY's Key Strengths?
Targeted exposure to emerging markets excluding China.
- Low beta indicating lower volatility.
- Established brand recognition.
- Transparent and rules-based index tracking.
What Are XCNY's Weaknesses?
Small market capitalization.
- Lack of dividend yield.
- Potential for higher expense ratios compared to broader market ETFs.
- Dependence on the performance of the S&P Emerging ex-China BMI.
What Are the Key Risks for XCNY?
Currency fluctuations in emerging markets can negatively impact returns for U.S. dollar-based investors.
- Political instability and geopolitical risks in emerging markets can disrupt economic activity and investor confidence.
- Changes in the composition of the S&P Emerging ex-China BMI could affect the ETF's performance and tracking accuracy.
- Economic slowdown in key emerging markets could negatively impact corporate earnings and investor returns.
What Are XCNY's Competitive Advantages?
- Established brand recognition as part of the State Street SPDR ETF family.
- Low expense ratio compared to actively managed emerging market funds.
- Accurate tracking of the S&P Emerging ex-China BMI.
- Diversified portfolio of emerging market equities.
What Does XCNY Do?
The State Street SPDR S&P Emerging Markets ex-China ETF (XCNY) was created to mirror the investment results of the S&P Emerging ex-China BMI. This index is designed to represent the performance of large, mid, and small-cap companies located in emerging markets, specifically excluding those domiciled in China. The ETF's strategy is to provide investors with a means to gain exposure to emerging markets while deliberately avoiding the Chinese market, allowing for a more tailored approach to managing country-specific risks. By excluding China, XCNY offers investors the opportunity to fine-tune their emerging market allocations. This can be particularly useful for those who have existing exposure to China through other investments or who have specific concerns about the Chinese market. The ETF's focus on other emerging economies allows investors to target growth and capital appreciation potential in regions such as Southeast Asia, Latin America, and Eastern Europe. The fund operates by holding a diversified portfolio of stocks that meet the index criteria, rebalancing periodically to maintain alignment with the index composition. This approach ensures that the ETF accurately reflects the performance of the underlying index, providing investors with a transparent and efficient way to access the emerging markets ex-China.
What Products and Services Does XCNY Offer?
- Tracks the performance of the S&P Emerging ex-China BMI.
- Provides exposure to emerging market equities excluding China.
- Offers investors a tool to manage China-specific risk.
- Invests in large, mid, and small-cap companies in emerging markets.
- Rebalances its portfolio to maintain alignment with the index.
- Seeks to provide investment results that correspond to the index's total return performance.
How Does XCNY Make Money?
- Generates revenue through management fees charged to investors.
- Aims to replicate the performance of the S&P Emerging ex-China BMI.
- Offers a diversified portfolio of emerging market equities excluding China.
What Industry Does XCNY Operate In?
The asset management industry is characterized by intense competition and evolving investor preferences. ETFs like XCNY cater to the growing demand for specialized investment strategies, allowing investors to target specific regions or sectors. The emerging markets ex-China segment is particularly appealing to those seeking growth opportunities while managing exposure to the Chinese economy. The competitive landscape includes other ETFs offering similar emerging market exposure, such as CARU, EMOP, EPEM and EPIN, requiring XCNY to differentiate itself through its index-tracking accuracy and cost-effectiveness.
Who Are XCNY's Key Customers?
- Retail investors seeking emerging market exposure.
- Institutional investors managing global portfolios.
- Financial advisors allocating client assets.
- Investors looking to manage China-specific risk.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is an etf, not an operating company
MoonshotScore History
Recorded daily since 2026-08-23 · 41 snapshots
| 2026-08-23 | 47 |
| 2026-08-31 | 47 |
| 2026-09-08 | 47 |
| 2026-09-16 | 47 |
| 2026-09-24 | 47 |
| 2026-10-04 | 47 |
What changed?
The score has stayed at 47.
Over the same 30 days the stock moved -0.4%.
XCNY Financials
Bull Case vs Bear Case
Bull Case
- Targeted exposure to emerging markets excluding China.
- Low beta indicating lower volatility.
- Established brand recognition.
- Transparent and rules-based index tracking.
Bear Case
- Small market capitalization.
- Lack of dividend yield.
- Potential for higher expense ratios compared to broader market ETFs.
- Dependence on the performance of the S&P Emerging ex-China BMI.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
XCNY Latest News
No recent news available for XCNY.
XCNY Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for XCNY.
Price Targets
Wall Street price target analysis for XCNY.
XCNY MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for XCNY; grades run from A+ (80-100) to F (below 30).
XCNY Financials Stock FAQ
What are the main risks for XCNY?
The main risks for XCNY include currency fluctuations in emerging markets, which can negatively impact returns for U.S. dollar-based investors.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Market data is as of 2026-03-17 and may not reflect current conditions.